Vimarsana
Biggest News Aggregation in the World

Page 2 - Clinical Laboratory Evaluation Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Laboratory Evaluation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Laboratory Evaluation Program Today - Breaking & Trending Today

Washington Healthcare Update - May 2024 #3 | McGuireWoods Consulting - Vimarsana News

Washington Healthcare Update - May 2024 #3 | McGuireWoods Consulting

This Week in Washington: House appropriators release FY2025 topline appropriations levels; Senate Finance Committee releases white paper on Medicare physician payment reforms; House...

United States - Life Sciences, Biotechnology & Nanotechnology - Final FDA Rule Regulating Laboratory Developed Tests - Vimarsana News

United States - Life Sciences, Biotechnology & Nanotechnology - Final FDA Rule Regulating Laboratory Developed Tests

On May 6, 2024, the Food and Drug Administration (FDA) issued its long-anticipated final rule regulating laboratory developed tests (LDTs).

Source: mondaq.com
LDT Final Rule: Shifting the LDT Battlefield | King & Spalding - Vimarsana News

LDT Final Rule: Shifting the LDT Battlefield | King & Spalding

On April 29, 2024, the Food and Drug Administration (“FDA” or “the Agency”) released a pre-publication version of the highly anticipated laboratory developed test final rule (“LDT Final...

FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests | Sheppard Mullin Richter & Hampton LLP - Vimarsana News

FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests | Sheppard Mullin Richter & Hampton LLP

Yesterday, the Food & Drug Administration (“FDA” or “the Agency”) issued a highly anticipated – and highly controversial – final rule, which rolls out a four-year, five-stage plan that...

FDA tightens scrutiny of lab-developed tests with new rule - Vimarsana News

FDA tightens scrutiny of lab-developed tests with new rule

The Food and Drug Administration (FDA) on Monday tightened regulations for clinical laboratories with a new rule that gives it more oversight of diagnostic tests developed by them.